| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 711830 | Null | 0.00662388971299133 | -0.3948671 |
| NSC 714407 | Null | 0.00662388971299133 | 0.27250595 |
| NSC 669145 | 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- | 0.00725424828633675 | -0.41485605 |
| NSC 756225 | GW410563A | 0.00741876119839025 | 0.29792604 |
| NSC 762557 | Null | 0.00741876119839025 | 0.34010708 |
| NSC 618759 | 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide | 0.00741876119839033 | -0.36309214 |
| NSC 633207 | Null | 0.00741876119839033 | -0.45815543 |
| NSC 658143 | 2-(1-(4-(2-(2-Hydroxyethoxy)ethyl)piperazino))naphthazarin | 0.00741876119839033 | -0.31425958 |
| NSC 666787 | Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate | 0.00741876119839033 | -0.16868429 |
| NSC 8120 | Claviform | 0.00770426557728501 | -0.26771082 |